. fueled by low vaccination rates led to 9,000 sick children and 10 infant deaths.. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said..
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..